EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ ALL ) and lymphoblastic lymphoma (T‐ LBL )

Miles Thomas iD, Apoorva Ravichandran iD, Emily Dworkin iD, Caner Saygin, Adam DuVall iD, Wendy Stock iD, Anand A Patel iD

British Journal of Haematology · 10.11.2026

DOI: 10.1111/bjh.70960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 10.11.2026. Verfasst von Miles Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Chicago, Chicago, Illinois, USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

T‐cell acute lymphoblastic leukaemiaT‐cell lymphoblastic lymphoma (T‐LBL)venetoclax

Autor:innen und Institutionen

  • Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Department of Pharmacy, University of Chicago, Chicago, Illinois, USA.
  • Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Miles Thomas, Apoorva Ravichandran, Emily Dworkin, Adam DuVall, Wendy Stock, Anand A Patel

Förderung

  • NCI NIH HHS

Zitieren

APA

Thomas, M., Ravichandran, A., Dworkin, E., Saygin, C., DuVall, A., Stock, W., & Patel, A. A. (2026). Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ ALL ) and lymphoblastic lymphoma (T‐ LBL ). British Journal of Haematology. https://doi.org/10.1111/bjh.70960

Vancouver

Thomas M, Ravichandran A, Dworkin E, Saygin C, DuVall A, Stock W, et al. Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ ALL ) and lymphoblastic lymphoma (T‐ LBL ). British Journal of Haematology. 2026. doi:10.1111/bjh.70960

BibTeX
@article{Thomas2026,
  author = {Thomas, Miles and Ravichandran, Apoorva and Dworkin, Emily and Saygin, Caner and DuVall, Adam and Stock, Wendy and Patel, Anand A},
  title = {Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ ALL ) and lymphoblastic lymphoma (T‐ LBL )},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70960}
}
Kostenlos starten →